NCT04657926View on ClinicalTrials.gov

A Trial of APPA in the Treatment of Knee Osteoarthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

September 30, 2021

Study Completion Date

October 1, 2021

Conditions
Osteoarthritis
Interventions
DRUG

APPA

APPA, an oral combination of two isomers: 4-hydroxy-3-methoxyacetophenone (4H3MA) \& 2-hydroxy-4-methoxyacetophenone (2H4MA).

DRUG

Placebo

Placebo capsules

Trial Locations (1)

Unknown

Sanos Clinic, Copenhagen

Sponsors
All Listed Sponsors
collaborator

NBCD A/S

INDUSTRY

lead

AKL Research and Development

INDUSTRY